BioSpace News Archive

March 11, 2020 13:00 UTC HGP & ALT to Conduct Auction of Assets From Five Prime Therapeutics’ South San Francisco Lab Online Auction Features State-of-the-Art Lab Equipment April 14, 2020 - April 16, 2020 https://www.hgpauction.com/auctions/102868/fiveprime/ SAN DIEGO--( BUSINESS WIRE )-- Heritage Global Partners (“HGP”), a worldwide leader in asset advisory and auction services, today announced that in partnership with American Laboratory Trading (“ALT”),

Burke Therapeutics, LLC, has signed an exclusive marketing and supply agreement with Coeptis Pharmaceuticals, Inc.

AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations across the nation, scored very high marks in the Human Rights Campaign 2020 Corporate Equality Index, the nation’s premier benchmarking survey and report measuring corporate policies and practices related to LGBTQ workplace equality.

Genesis HealthCare announced that it is moving the release of its fourth quarter and year end December 31, 2019 results to after the market closes on Monday, March 16, 2020.

The Government of Canada is working closely with local, provincial, territorial, and international partners to minimize its health, economic, and social impacts in Canada and around the world.

NeuroMetrix, Inc.today provided an update on its Quell technology commercial strategy and pipeline.

With the outbreak of COVID-19, known as the coronavirus, Electronic Caregiver®, a 24/7 virtual care and health technology company, will begin using its own products to monitor the health of all its workers before they head to the office.

XtalPi Inc. (“XtalPi”), an algorithm-driven artificial intelligence (AI) pharmaceutical technology company, and Porton Pharma Solutions Ltd. (“Porton”), a contract development and manufacturing organization (CDMO), announces the signing of a strategic collaboration to integrate XtalPi’s next-generation computational tools with Porton’s experimental expertise to further empower pharmaceutical research in drug design and pre-clinical development.

Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, publishes its financial results for 2019 and provides an update on its product portfolio.

CVS Health Corporation announced that its board of directors has approved a quarterly dividend of $0.50 per share on the corporation’s common stock.